FEDERAL COURT OF AUSTRALIA
Eli Lilly & Company v Pfizer Ireland Pharmaceuticals (No 3) [2004] FCA 1085
INTELLECTUAL PROPERTY – patents – application to rely on experiments conducted in the United States as experimental proof – whether applicants concealed experimental evidence – whether respondents would be prejudiced if experiments could be relied on
Federal Court Rules, O 58 r 31
ELI LILLY & COMPANY & ORS V PFIZER IRELAND PHARMACEUTICALS & ANOR
V604 OF 2002HEEREY J
16 AUGUST 2004
MELBOURNE
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
V604 OF 2002
BETWEEN:
ELI LILLY & COMPANY
FIRST APPLICANT/FIRST CROSS-RESPONDENTELI LILLY AUSTRALIA PTY LTD
ACN 000 233 992
SECOND APPLICANT/SECOND CROSS-RESPONDENTELI LILLY & COMPANY LIMITED
THIRD APPLICANT/THIRD CROSS-RESPONDENTAND:
PFIZER IRELAND AND PHARMACEUTICALS
FIRST RESPONDENT/FIRST CROSS-CLAIMANTPFIZER PTY LIMITED ACN 008 422 348
SECOND RESPONDENT/SECOND CROSS-CLAIMANTJUDGE:
HEEREY J
DATE OF ORDER:
16 AUGUST 2004
WHERE MADE:
MELBOURNE
THE COURT ORDERS THAT:
- Leave be granted to the applicants/cross-respondents to rely on affidavits in admissible form substantially in accordance with the declarations of Dr Vincent Florio and Dr Philip Iverson annexed to the notice of motion dated 10 August 2004 as evidence derived from experimental proof of a matter as evidence in this proceeding.
- The applicants/cross-respondents pay the applicants costs of the motion.
Note: Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
V604 OF 2002
BETWEEN:
ELI LILLY & COMPANY
FIRST APPLICANT/FIRST CROSS-RESPONDENTELI LILLY AUSTRALIA PTY LTD ACN 000 233 992
SECOND APPLICANT/SECOND CROSS-RESPONDENTELI LILLY & COMPANY LIMITED
THIRD APPLICANT/THIRD CROSS-RESPONDENTAND:
PFIZER IRELAND AND PHARMACEUTICALS
FIRST RESPONDENT/FIRST CROSS-CLAIMANTPFIZER PTY LIMITED ACN 008 422 348
SECOND RESPONDENT/SECOND CROSS-CLAIMANT
JUDGE:
HEEREY J
DATE:
16 AUGUST 2004
PLACE:
MELBOURNE
REASONS FOR JUDGMENT
This is an application for leave to rely on evidence derived from experimental proof. Alternatively the applicants seek directions for the conduct of further experiments pursuant to O 58 r 31 of the Federal Court Rules. The circumstances are described in the two affidavits of Mr Grant William Fisher sworn 10 and 11 August 2004 and the affidavit of Mr Stephen Marcus Stern sworn 16 August 2004. I also refer to the applicants’ written submissions handed to me today.
In my view there is no reasonable basis for inferring a deliberate course of concealment on the part of Eli Lilly. The experiments of Dr Florio seem to have been conducted for a purpose quite unrelated to the present proceeding, that is to say for US Patent Office re-examination proceedings. I think also it is reasonable to draw the conclusion that it was not until the letter of 5 April 2004 that it became clear to Lilly that the construction of claim 10 of the patent in suit referred to in that letter was to be relied on by Pfizer in the Australian proceeding.
It is true there has been less than admirable promptness between that date and…
Keep reading for free
Create a free CaseChat account to read Eli Lilly and Company v Pfizer Ireland Pharmaceuticals (No 3... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2004] FCA 1085
- Decision Date
CaseChat Overview and Summary
The legal issues before the court were whether the affidavits in question could be admitted as evidence and, if so, under what conditions. The court needed to determine whether the affidavits met the criteria for admissibility as experimental proof and whether they should be allowed as evidence in the proceeding. The admissibility of such evidence is a matter of significant importance in patent litigation, where the ability to rely on experimental proof can influence the outcome of the case.
The court granted leave for the applicants/cross-respondents to rely on affidavits substantially in accordance with the declarations of Dr Vincent Florio and Dr Philip Iverson. These affidavits were deemed to be admissible as evidence derived from experimental proof, provided they met certain conditions. The court ordered that the applicants/cross-respondents bear the costs of the motion. The decision emphasised the importance of ensuring that the evidence is reliable and relevant to the issues at hand. The court's reasoning was based on the need to balance the protection of intellectual property rights with the need for fair and just proceedings in patent litigation.
Orders
Orders of the court
1. Leave be granted to the applicants/cross-respondents to rely on affidavits in admissible form substantially in accordance with the declarations of Dr Vincent Florio and Dr Philip Iverson annexed to the notice of motion dated 10 August 2004 as evidence derived from experimental proof of a matter as evidence in this proceeding.
2. The applicants/cross-respondents pay the applicants costs of the motion.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Established by: HEEREY J